Eliot Brinton, MD, opens a discussion surrounding the treatment landscape for patients with homozygous familial hypercholesterolemia (HoFH). Eliot Brinton, MD: I’m Dr Elliot Brinton. I’m the president ...

Medical experts illustrate an array of characteristics presented in patients with HoFH. Erin Michos, MD, MHS: In homozygous FH [familial hypercholesterolemia], the LDL [low-density lipoprotein] ...

Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...

Homozygous familial hypercholesterolemia (HoFH) is an inherited condition that increases blood cholesterol and a person’s risk of heart disease. Medications can help lower blood cholesterol levels.

– Confirms Sufficient Data to Complete Phase 2 Clinical Study Enrollment and Advance to Phase 3 Studies in Both Heterozygous and Homozygous Familial Hypercholesterolemia – – Establishes Pediatric Path ...

Student teams analyze genetic test results for fictional characters, compare their characters' risks of developing specific diseases, and assess the risks for the next generation. Can genetic testing ...

A 58-year-old woman with debilitating ankylosing spondylitis who was born to consanguineous parents was found to have an apparent severe vitamin D deficiency that did not respond to supplementation.

--Amgen today announced positive data from the HAUSER-RCT Phase 3 b study evaluating the safety and efficacy of Repatha ® in pediatric patients, 10-17 years of age, with heterozygous familial ...